Increased Proportions of Bifidobacterium and the Lactobacillus Group and Loss of Butyrate-Producing Bacteria in Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Dysbiosis in the intestinal microbiota of persons with inflammatory bowel disease (IBD) has been described, but there are still varied reports on changes in the abundance of Bifidobacterium and Lactobacillus organisms in patients with IBD. The aim of this investigation was to compare the compositions of mucosa-associated and fecal bacteria in patients with IBD and in healthy controls (HCs). Fecal and biopsy samples from 21 HCs, 21 and 15 Crohn's disease (CD) patients, and 34 and 29 ulcerative colitis (UC) patients, respectively, were analyzed by quantitative real-time PCR targeting the 16S rRNA gene. The bacterial numbers were transformed into relative percentages for statistical analysis. The proportions of bacteria were uniformly distributed along the colon regardless of the disease state. Bifidobacterium was significantly increased in the biopsy specimens of active UC patients compared to those in the HCs (4.6% versus 2.1%, P = 0.001), and the proportion of Bifidobacterium was significantly higher in the biopsy specimens than in the fecal samples in active CD patients (2.7% versus 2.0%, P = 0.012). The Lactobacillus group was significantly increased in the biopsy specimens of active CD patients compared to those in the HCs (3.4% versus 2.3%, P = 0.036). Compared to the HCs, Faecalibacterium prausnitzii was sharply decreased in both the fecal and biopsy specimens of the active CD patients (0.3% versus 14.0%, P < 0.0001 for fecal samples; 0.8% versus 11.4%, P < 0.0001 for biopsy specimens) and the active UC patients (4.3% versus 14.0%, P = 0.001 for fecal samples; 2.8% versus 11.4%, P < 0.0001 for biopsy specimens). In conclusion, Bifidobacterium and the Lactobacillus group were increased in active IBD patients and should be used more cautiously as probiotics during the active phase of IBD. Butyrate-producing bacteria might be important to gut homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with inflammatory bowel disease (IBD) have been associated with reduced bacterial diversity and a decline in butyrate-producing bacteria such as Faecalibacterium prausnitzii, indicating the importance of gut dysbiosis in IBD [138, 139].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [139]
In the citing paper
“mucosa-associated microbes preferentially regulate host homeostasis, as is evident in the induction of T-cell immune responses, as well as maintaining serotonin biosynthesis from dietary tryptophan in the mucosa.28, 29, 30, 31, 32, 33”
From Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder (2017) · cites this paper as [28]
Citations
Cites
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029 · cited 1×
“In our study, we found that the proportions of detected mucosa-associated bacteria in healthy gastrointestinal tracts were uniformly distributed along the colon, which was in accordance with the findings from a previous study (23, 24).”
ResultFrank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 2×
“leptum group was strikingly low in mucosa-associated microbiotas (40, 41).”
BackgroundSokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · cited 1×
“One study suggested that Faecalibacterium prausnitzii prevents 2,4,6-trinitrobenzenesulfonic acid (TNBS)induced colitis (16).”
BackgroundDevelopment of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
Microbial Influences in Inflammatory Bowel Diseases
Sartor, R. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.059 · Cited by 1,927
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
Sartor, R. B. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0528 · Cited by 1,757
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Mucosal flora in inflammatory bowel disease
Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening–Baucke, V., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30294 · Cited by 1,346
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285
Cited by
Items 101–200 of 510
Kim, E. S., Tarassishin, L., Eisele, C. D., Barré, A., Nair, N. K., Rendon, A. P., Hawkins, K. A., Debebe, A., White, S. R., Thjømøe, A., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.11.050 · Cited by 101
Manandhar, I., Alimadadi, A., Aryal, S., Munroe, P. B., Joe, B., & Cheng, X. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00360.2020 · Cited by 91
Functions of the Microbiota for the Physiology of Animal Metaorganisms
Esser, D., Lange, J., Μαρίνος, Γ., Sieber, M., Best, L., Prasse, D., Bathia, J., Rühlemann, M. C., Boersch, K., Jaspers, C., et al. (2018) · Journal of Innate Immunity · doi:10.1159/000495115 · Cited by 98
Gut Microbiome in Inflammatory Bowel Disease and Other Chronic Immune-Mediated Inflammatory Diseases
Bernstein, C. N., & Forbes, J. D. (2017) · Inflammatory Intestinal Diseases · doi:10.1159/000481401 · Cited by 99
The functions of gut microbiota-mediated bile acid metabolism in intestinal immunity
He, Y., Shaoyong, W., Chen, Y., Li, M., Gan, Y., Sun, L., Liu, Y., Wang, Y., & Jin, M. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.015 · Cited by 124
Yue, B., Luo, X., Yu, Z., Mani, S., Wang, Z., & Dou, W. (2019) · Microorganisms · doi:10.3390/microorganisms7100440 · Cited by 94
“Moreover, decreased abundance of Clostridium cluster IV (the Clostridium leptum group), especially Faecalibacterium prausnitzii, has been reported [40,41].”
BackgroundThe fecal microbiota as a biomarker for disease activity in Crohn’s disease
Tedjo, D. I., Smolinska, A., Savelkoul, P. H. M., Masclee, A., van Schooten, F., Pierik, M. J., Penders, J., & Jonkers, D. M. A. E. (2016) · Scientific Reports · doi:10.1038/srep35216 · Cited by 98
The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review
Aldars‐García, L., Marín, A. C., Chaparro, M., & Gisbert, J. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063076 · Cited by 98
“However, controversial results were found within this genus, as other authors also reported its increase in IBD patients compared to controls [47,48,63,100].”
ResultAltomare, A., Putignani, L., CHIERICO, F. D., Cocca, S., Angeletti, S., Ciccozzi, M., Tripiciano, C., Piccola, B. D., Cicala, M., & Guarino, M. P. L. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.11.021 · Cited by 99
Wu, M., Li, J., An, Y., Li, P., Xiong, W., Li, J., Yan, D., Wang, M., & Zhong, G. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02101 · Cited by 88
Emerging connections between gut microbiome bioenergetics and chronic metabolic diseases
Daisley, B. A., Koenig, D. W., Engelbrecht, K. C., Doney, L., Hards, K., Al, K. F., Reid, G., & Burton, J. P. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110087 · Cited by 92
Knox, N., Forbes, J. D., Peterson, C.-L., Domselaar, G. V., & Bernstein, C. N. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000305 · Cited by 95
The role of short-chain fatty acids in central nervous system diseases
Dong, Y., & Cui, C. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04471-8 · Cited by 90
Paljetak, H. Č., Barešić, A., Panek, M., Perić, M., Matijašić, M., Lojkić, I., Barišić, A., Bender, D. V., Kelečić, D. L., Brinar, M., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2083419 · Cited by 96
“One of the major findings of this study is the spatial homogeneity of microbiota along the colon based on the lack of community level differences or specific microbial structure that would characterize an anatomical site, as previously shown at 2 to 4 anatomical sites along the gut in IBD patients undergoing treatment…”
BackgroundResultGut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease
Pandey, H., Jain, D., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Intestinal Research · doi:10.5217/ir.2023.00080 · Cited by 102
Huang, A., Cai, R., Wang, Q., Shi, L., Li, C., & Yan, H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00322 · Cited by 92
Wang, Y., Zou, Y., Wang, J., Ma, H., Zhang, B., & Wang, S. (2020) · Nutrients · doi:10.3390/nu12051284 · Cited by 85
Association between intestinal microbiota and inflammatory bowel disease
Zhang, Y., Si, X., Yang, L., Wang, H., Sun, Y. Q., & Liu, N. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12255 · Cited by 90
Targeting the Gut–Eye Axis: An Emerging Strategy to Face Ocular Diseases
Campagnoli, L. I. M., Varesi, A., Barbieri, A., Marchesi, N., & Pascale, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713338 · Cited by 99
Inflammatory Bowel Disease–Associated Changes in the Gut: Focus on Kazan Patients
Sasso, G. L., Khachatryan, L., Kondylis, A., Battey, J. N. D., Sierro, N., Danilova, N. A., Grigoryeva, T. V., Markelova, M., Khusnutdinova, D. R., Laikov, A. V., et al. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa188 · Cited by 85
“33 It is worth noting that Bifidobacterium species are phylogenetically diverse, with more than 50 documented species to date.”
BackgroundGut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease
Markandey, M., Bajaj, A., Ilott, N. E., Kedia, S., Travis, S. P. L., Powrie, F. M., & Ahuja, V. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1990827 · Cited by 88
Role of colonic microbiota in the pathogenesis of ulcerative colitis
Pei, L.-Y., Ke, Y.-S., Zhao, H., Wang, L., Jia, C., Liu, W., Fu, Q.-H., Shi, M.-N., Cui, J., & Li, S. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-0930-3 · Cited by 89
The fecal microbiome of dogs with exocrine pancreatic insufficiency
Isaiah, A., Parambeth, J. C., Steiner, J. M., Lidbury, J. A., & Suchodolski, J. S. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.02.010 · Cited by 91
The role of the Hippo pathway in the pathogenesis of inflammatory bowel disease
Xie, Z., Wang, Y., Yang, G., Han, J., Zhu, L., Li, L., & Zhang, S. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03395-3 · Cited by 84
Implication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer
Singh, S., Sharma, P., Sarma, D. K., Kumawat, M., Tiwari, R. R., Verma, V., Nagpal, R., & Kumar, M. (2023) · Cancers · doi:10.3390/cancers15061913 · Cited by 91
Unraveling the Role of the Human Gut Microbiome in Health and Diseases
Khalil, M., Ciaula, A. D., Mahdi, L., Jaber, N., Palo, D. M. D., Graziani, A., Baffy, G., & Portincasa, P. (2024) · Microorganisms · doi:10.3390/microorganisms12112333 · Cited by 114
“The Firmicutes species include Clostridium leptum , F. prausnitzii [366,388], and the butyric-acid-producing Roseburia spp. [389].”
Recent Advances on Microbiota Involvement in the Pathogenesis of Autoimmunity
Gianchecchi, E., & Fierabracci, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020283 · Cited by 85
“Reduction of several butyrate-producing bacteria [74,76]”
ResultInfluentialFrom taxonomy to metabolic output: what factors define gut microbiome health?
Wilmanski, T., Rappaport, N., Diener, C., Gibbons, S. M., & Price, N. D. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1907270 · Cited by 73
Mayers, M., Moon, C., Stupp, G. S., Su, A. I., & Wolan, D. W. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00938 · Cited by 85
Zou, S., Zhang, J., & Zhang, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184394 · Cited by 76
Gut microbiome and frailty: insight from genetic correlation and mendelian randomization
Cui, G., Li, S., Ye, H., Yang, Y., Jia, X., Lin, M., Chu, Y., Feng, Y., Wang, Z., Shi, Z., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2282795 · Cited by 89
“A previous case-control study also found a significantly higher proportion of Bifidobacterium in patients with active inflammatory bowel than in healthy controls 57 .”
MethodZhao, H., Xu, H., Chen, S., He, J., Zhou, Y., & Nie, Y. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15222 · Cited by 83
Epithelial Transport in Inflammatory Bowel Diseases
Ghishan, F. K., & Kiela, P. R. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000029 · Cited by 70
Voisine, J., & Abadie, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.674313 · Cited by 87
Libertucci, J., Dutta, U., Kaur, S., Jury, J., Rossi, L., Fontes, M. E., Shajib, M. S., Khan, W. I., Surette, M. G., Verdu, E. F., et al. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00411.2017 · Cited by 80
“compared with non-IBD controls, which have reported that CD is associated with a decrease in the phylum Firmicutes (thought to cause a decrease in luminal abundance of short-chain fatty acid producers) (11, 29, 32, 42), an increase in proinflammatory bacteria such as Fusobacteria, and a decrease in Faecalibacterium pr…”
ResultUngaro, F., Massimino, L., D’Alessio, S., & Danese, S. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619876787 · Cited by 81
MicroRNAs-Based Inter-Domain Communication between the Host and Members of the Gut Microbiome
Williams, M. R., Stedtfeld, R. D., Tiedje, J. M., & Hashsham, S. A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01896 · Cited by 74
“prausnitzii in UC andCrohn’s disease has also associated with an increase in other gut commensals such as Bifidobacterium and Lactobacillus (Wang et al., 2014).”
BackgroundSchierová, D., Březina, J., Mrázek, J., Fliegerova, K. O., Kvasnová, S., Bajer, L., & Drastich, P. (2020) · Cells · doi:10.3390/cells9102283 · Cited by 72
“Several studies show that Lactobacillus is depleted in IBS patients [90,91], decreased in UC patients [65], and increased in CD patients [92].”
ResultMicrobiome–Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases
Fofanova, T. Y., Petrosino, J. F., & Kellermayer, R. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000950 · Cited by 72
Jadhav, A., Jagtap, S., Vyavahare, S., Sharbidre, A. A., & Kunchiraman, B. N. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1268041 · Cited by 80
Caenepeel, C., Tabib, N. S. S., Vieira‐Silva, S., & Vermeire, S. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16096 · Cited by 72
IBD and the Gut Microbiota—from Bench to Personalized Medicine
Bellaguarda, E., & Chang, E. B. (2015) · Current Gastroenterology Reports · doi:10.1007/s11894-015-0439-z · Cited by 67
Romano, S., Wirbel, J., Ansorge, R., Schudoma, C., Ducarmon, Q. R., Narbad, A., & Zeller, G. (2025) · Nature Communications · doi:10.1038/s41467-025-56829-3 · Cited by 85
“Alignment counts for a gene were normalised by the gene ’ s length, then scaled according to the strategy employed by NGLess (https://ngless.embl.de/Functions.html#count) and propagated to the functional features with which the gene is annotated.”
Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn’s Disease
Galazzo, G., Tedjo, D. I., Wintjens, D., Savelkoul, P. H. M., Masclee, A., Bodelier, A. G. L., Pierik, M. J., Jonkers, D. M. A. E., & Penders, J. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz049 · Cited by 72
Identification of a Shared Microbiomic and Metabolomic Profile in Systemic Autoimmune Diseases
Bellocchi, C., Fernández‐Ochoa, Á., Montanelli, G., Vigone, B., Santaniello, A., Quirantes‐Piné, R., Borrás‐Linares, I., Gerosa, M., Artusi, C., Gualtierotti, R., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091291 · Cited by 63
“Bifidobacterium is known to be increased in active phase of inflammatory bowel disease [45]; similarly, Streptococcus has been associated with inflammatory intestinal conditions [46].”
BackgroundDrugs and Bugs: The Gut-Brain Axis and Substance Use Disorders
Simpson, S., Mclellan, R., Wellmeyer, E., Matalon, F., & George, O. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10022-7 · Cited by 70
“This shift in community makeup is also found in inflammatory diseases like psoriatic arthritis and inflammatory bowel disease (Scher et al. 2015; Wang et al. 2014).”
Microbial Metabolite Regulation of Epithelial Cell-Cell Interactions and Barrier Function
Ornelas, A., Dowdell, A. S., Lee, J. S., & Colgan, S. P. (2022) · Cells · doi:10.3390/cells11060944 · Cited by 76
Microbial Butyrate Synthesis Indicates Therapeutic Efficacy of Azathioprine in IBD Patients
Effenberger, M., Reider, S., Waschina, S., Bronowski, C., Enrich, B., Adolph, T. E., Koch, R., Moschen, A. R., Rosenstiel, P. C., Aden, K., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa152 · Cited by 64
Regulation of Oxygen Homeostasis at the Intestinal Epithelial Barrier Site
Konjar, Š., Pavšič, M., & Veldhoen, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179170 · Cited by 64
“In contrast, in mice that were on high-fat, low-fibre diet and with consequently low butyrate production, there was an increase in CD3+ intraepithelial lymphocytes and CD68+ lamina propria macrophages, suggesting increased inflammation in the absence of fibre degradation and SCFA production [75].”
BackgroundUlcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier
Chen, S.-J., Liu, X.-W., Liu, J.-P., Yang, X.-Y., & Lu, F.-G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i28.9468 · Cited by 58
Teofani, A., Marafini, I., Laudisi, F., Pietrucci, D., Salvatori, S., Unida, V., Biocca, S., Monteleone, G., & Desideri, A. (2022) · Nutrients · doi:10.3390/nu14020260 · Cited by 71
“The abundance of Bifidobacterium is known to be strictly dependent on the disease phase [54], thus providing a possible explanation for the discrepancy between our results and previous observations.”
ResultMicrobiome and metabolome in inflammatory bowel disease
Upadhyay, K. G., Desai, D., Ashavaid, T. F., & Dherai, A. J. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16043 · Cited by 66
Stem Cell-Based Therapies for Inflammatory Bowel Disease
Zhang, H., Yuan, S., Meng, H., Hou, X.-T., Li, J., Xue, J.-C., Li, Y., Wang, Q., Nan, J., Jin, X., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158494 · Cited by 62
“When microbial homeostasis is disrupted, intestinal colonization resistance is greatly reduced, which can lead to the colonization and invasion of opportunistic pathogens in the intestine, thereby increasing the risk of eliciting host immune responses and inducing or even promoting the development of IBD [27].”
BackgroundCui, X., Wang, X., Chang, X., Bao, L., Wu, J., Tan, Z., Chen, J., Li, J., Gao, X., Ke, P. C., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2218739120 · Cited by 60
“…of gut microbiota has been domesticated to recognize exogenous nano coronaviruses or plastics (58, 59); 2) Gut microbiota are highly enriched for genes involved in carbon metabolism (49, 50), thus facilitating the host to extract calories from their normal diet or unconventional diet/source (CNMs).”
BackgroundSelf-citationGut Microbiota Serves as a Crucial Independent Biomarker in Inflammatory Bowel Disease (IBD)
Sharma, B., Agriantonis, G., Twelker, K., Ebelle, D., Kiernan, S., Siddiqui, M., Soni, A., Cheerasarn, S., Simon, W., Jiang, W., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062503 · Cited by 65
Robinson, A. M., Gondalia, S. V., Karpe, A. V., Eri, R. D., Beale, D. J., Morrison, P. D., Palombo, E. A., & Nurgali, K. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000970 · Cited by 60
Miguel, M. A., Lee, S. S., Mamuad, L. L., Choi, Y. J., Jeong, C. D., Son, A., Cho, K. K., Kim, S. B., Kim, S. B., & Lee, S. (2019) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1905.05016 · Cited by 65
The Role of the Microbiota in Graves’ Disease and Graves’ Orbitopathy
Hou, J., Tang, Y., Chen, Y., & Chen, D. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.739707 · Cited by 62
Girotra, M., Garg, S., Anand, R., Song, Y., & Dutta, S. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4229-8 · Cited by 57
Gut microbiota in children and altered profiles in juvenile idiopathic arthritis
Filippo, C. D., Paola, M. D., Giani, T., Tirelli, F., & Cimaz, R. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.01.001 · Cited by 64
Adenovirus infection is associated with altered gut microbial communities in a non-human primate
Wasimuddin, Corman, V. M., Ganzhorn, J. U., Rakotondranary, J., Ratovonamana, Y. R., Drosten, C., & Sommer, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-49829-z · Cited by 58
Ventura, I., Chomon-García, M., Tomás‐Aguirre, F., Palau-Ferrè, A. M., Legidos‐Garcia, M. E., Murillo-Llorente, M. T., & Pérez-Bermejo, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010879 · Cited by 65
“It is essential that future studies address these limitations by using rigorous and standardized methodological designs and including diverse populations to validate and extend these findings.”
BackgroundBakır-Güngör, B., Hacılar, H., Jabeer, A., Nalbantoğlu, Ö. U., Aran, O., & Yousef, M. (2022) · PeerJ · doi:10.7717/peerj.13205 · Cited by 61
Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn’s Disease Exacerbations
Klaassen, M. A. Y., Imhann, F., Collij, V., Fu, J., Wijmenga, C., Zhernakova, A., Dijkstra, G. D. H., Festen, E. A. M., Gaćeša, R., Vila, A. V., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz077 · Cited by 59
Xu, N., Bai, X., Cao, X., Yue, W., Jiang, W., & Yu, Z. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104707 · Cited by 59
Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
Nishida, A., Nishino, K., Sakai, K., Owaki, Y., Noda, Y., & Imaeda, H. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i23.3317 · Cited by 54
Breaking down the gut microbiome composition in multiple sclerosis
Budhram, A., Parvathy, S., Kremenchutzky, M., & Silverman, M. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458516682105 · Cited by 51
Sun, M., Li, D., Mei, H., Miao, X., Su, Y., Chi, Y., Li, Y., Sun, R., Niu, H., & Wang, J. (2022) · Food & Function · doi:10.1039/d2fo01165d · Cited by 56
Enteric microbiota leads to new therapeutic strategies for ulcerative colitis
Chen, W.-X., Ren, L., & Shi, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15657 · Cited by 64
Bamola, V. D., Dubey, D., Samanta, P., Kedia, S., Ahuja, V., Madempudi, R. S., Neelamraju, J., & Chaudhry, R. (2022) · Anaerobe · doi:10.1016/j.anaerobe.2022.102652 · Cited by 64
Singh, R., Nieuwdorp, M., ten Berge, I. J. M., Bemelman, F. J., & Geerlings, S. E. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12799 · Cited by 54
“Many studies have found that IBD patients have a reduced amount of this bacterium in their gut microbiota [17–20].”
BackgroundHong, C., Chen, S.-Y., Hsu, Y., & Yen, G. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111390 · Cited by 58
Impact of Microbiome–Brain Communication on Neuroinflammation and Neurodegeneration
Stolzer, I., Scherer, E., Süß, P., Rothhammer, V., Winner, B., Neurath, M. F., & Günther, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914925 · Cited by 50
“Of particular note, the abundance of Bifidobacterium and Lactobacillus can be modulated via PD medication [143,183,184] and is correlated with clinical inflammatory indicators, such as the percentages of neutrophils and monocytes [185], and associated with active IBD [186].”
Wu, Z.-Y., Pan, D., Jiang, M., Sang, L.-X., & Chang, B. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.716816 · Cited by 57
Characteristics of the intestinal microbiome in ankylosing spondylitis
Cardoneanu, A., Cozma, S. R., Rezuș, C., Petrariu, F. D., Burlui, A., & Rezuş, E. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10108 · Cited by 52
“The primer structures were taken from an article published by Wang et al (27) and verified using OligoAnalyzer 3.”
MethodInfluentialFernández‐Tomé, S., Marín, A. C., Moreno, L. O., Martin, M. B., Mora‐Gutiérrez, I., Lanas-Gimeno, A., Moreno-Monteagudo, J. A., Santander, C., Sánchez, B., Chaparro, M., et al. (2019) · Nutrients · doi:10.3390/nu11112605 · Cited by 49
Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment
Yuan, S., Wang, Q., Li, J., Xue, J.-C., Li, Y., Meng, H., Hou, X.-T., Nan, J., & Zhang, Q. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00633-4 · Cited by 56
“It has been shown that during the active phase of IBD, there is intestinal flora dysbiosis and decreased species diversity within the organism [21].”
BackgroundYao, Y., Liu, Y., Xu, Q., & Mao, L. (2024) · Molecules · doi:10.3390/molecules29020379 · Cited by 48
“For example, Wang et al. found that the loss of butyrate-producing Faecalibacterium prausnitzii was associated with the increased proportion of Bifidobacterium and the Lactobacillus in both fecal and biopsy specimens of IBD patients [36].”
BackgroundAmorim, C., Silvério, S. C., Cardoso, B. B., Alves, J. I., Pereira, M. A., & Rodrigues, L. R. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115460 · Cited by 53
“IBD active patients present increased proportions of Bifidobacterium and Lactobacillus on their intestinal microbiota and reduced butyrate-producing bacteria (Wang et al., 2014).”
BackgroundXu, Z., Tang, H., Huang, F., Qiao, Z., Wang, X., Yang, C., & Deng, Q. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.615404 · Cited by 50
Self-citationThe gut microbiota heterogeneity and assembly changes associated with the IBD
Sun, Y., Li, L., Yao, X. Y., Li, W., Wang, K., Wang, L., Miao, Y., & Ma, S. (2019) · Scientific Reports · doi:10.1038/s41598-018-37143-z · Cited by 48
Pandit, L., Cox, L. M., Malli, C., D’Cunha, A., Rooney, T., Lokhande, H. A., Willocq, V., Saxena, S., & Chitnis, T. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000907 · Cited by 51
“Bifidobacterium species was reduced in patients, and this has been previously reported with another autoimmune disorder namely Crohn’s disease.(34) Clostridium bolteae was also increased in a small number of seronegative patients with NMOSD.”
ResultKrueger, M. E., Boles, J. S., Simon, Z. D., Alvarez, S. D., McFarland, N. R., Okun, M. S., Zimmermann, E. M., Forsmark, C. E., & Tansey, M. G. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00894-4 · Cited by 57
The role of IL-10 in microbiome-associated immune modulation and disease tolerance
Levast, B., Li, Z., & Madrenas, J. (2014) · Cytokine · doi:10.1016/j.cyto.2014.11.027 · Cited by 52
Dysbiosis of Gut Microbiome and Its Impact on Epigenetic Regulation
Lee, E. S., Song, E., & Nam, Y. D. (2017) · Journal of Clinical Epigenetics · doi:10.21767/2472-1158.100048 · Cited by 47
Boland, K., Bedrani, L., Turpin, W., Kabakchiev, B., Stempak, J. M., Borowski, K., Nguyen, G. C., Steinhart, A. H., Smith, M. I., Croitoru, K., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.03.044 · Cited by 42
Scharf, M. W., Marques, T. M., Markgren, M., Löfvendahl, L., Brummer, R. J., & Wall, R. (2020) · Biomolecules · doi:10.3390/biom10050766 · Cited by 46
Al-Amrah, H., Saadah, O. I., Mosli, M. H., Annese, V., Al-Hindi, R. R., Edris, S., Alshehri, D., Alatawi, H. A., Alatawy, M., & Bahieldin, A. (2023) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_368_22 · Cited by 45
Li, Y., Luan, Y., Yue, X., Xiang, F., Mao, D., Cao, Y., & Xiong, Z. Q. (2018) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2018.11.008 · Cited by 42
Li, W., Zhang, Y., Chen, M., Guo, X., & Ding, Z. (2024) · Food & Function · doi:10.1039/d3fo05337g · Cited by 43
Paudel, D., Nair, D. V. T., Tian, S., Hao, F., Goand, U. K., Joseph, G., Prodes, E., Chai, Z., Robert, C. E. M., Chassaing, B., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2341457 · Cited by 48
“62 Further analysis of gut microbiota composition revealed that guar gum-induced genus-level alterations in phyla Bacteroidota and Firmicutes favoring the enrichment of intermediate metabolite such as lactate and succinate by promoting expansion of succinate and lactate producer ( Bifidobacterium…”
BackgroundShabani, M., Ghoshehy, A., Mottaghi, A. M., Chegini, Z., Kerami, A., Shariati, A., & Moghadam, M. T. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1516010 · Cited by 58
Izumi, H., Minegishi, M., Sato, Y., Shimizu, T., Sekine, K., & Takase, M. (2015) · Pediatric Research · doi:10.1038/pr.2015.115 · Cited by 42
The alterations of gut microbiota in mice with chronic pancreatitis
Han, M., Zhu, X., Peng, Y., Lin, H., Liu, D., & Li, L. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.08.18 · Cited by 40
“Some studies have been reported higher prevalence of Lactobacillus and Bifidobacterium in gastrointestinal disorders (44).”
BackgroundGastrointestinal Microbiome – What We Need to Know in Clinical Practice
Ortigão, R., Pimentel‐Nunes, P., Dinis-Ribeiro, M. J., & Libânio, D. (2020) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000505036 · Cited by 46
Šoltýs, K., Stuchlíková, M., Hlavatý, T., Gaálová, B., Budiš, J., Gazdarica, J., Krajčovičová, A., Zelinková, Z., Szemes, T., Kuba, D. M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62811-4 · Cited by 43
Ma, B., Barathan, M., Ng, M. H., & Law, J. X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073148 · Cited by 44
“Beneficial bacteria, such as Bifidobacterium and Lactobacillus, which are known for their anti-inflammatory properties and ability to maintain intestinal barrier function, are found at lower levels in patients with CD [107].”
Nunez, N., Réot, L., & Menu, E. (2021) · Vaccines · doi:10.3390/vaccines9060584 · Cited by 42
The Rundown of Dietary Supplements and Their Effects on Inflammatory Bowel Disease—A Review
Malinowski, B., Wiciński, M., Sokołowska, M. M., Hill, N. A., & Szambelan, M. (2020) · Nutrients · doi:10.3390/nu12051423 · Cited by 46
“Escherichia coli was also found in abundance in both types of IBD patients, yet, a higher proportion in active UC patients [12].”
BackgroundGerges, M. A., Esmaeel, N. E., Makarm, W. K., Sharaf, D. M., & Gebriel, M. G. (2021) · International Journal of Microbiology · doi:10.1155/2021/9934533 · Cited by 39
“All bacteria (universal) F-ACTCCTACGGGAGGCAGCAGT [11] R-GTATTACCGCGGCTGCTGGCAC”
Metadata
- Authors
- Wang, W., Chen, L., Zhou, R., Wang, X., Song, L., Huang, S., Wang, G., & Xia, B.
- Affiliations
- Zhongnan Hospital of Wuhan University (CN)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2014-02
- Volume
- 52
- Issue
- 2
- Pages
- 398-406
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC3911339
- OpenAlex
- W2097788076
- Cited by
- 509
- References
- 48
- Citations by year
- 2026: 26 · 2025: 46 · 2024: 47 · 2023: 56 · 2022: 74 · 2021: 56 · 2020: 53 · 2019: 39 · 2018: 29 · 2017: 24 · 2016: 28 · 2015: 12 · 2014: 19
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, gut dysbiosis, Bifidobacterium, Lactobacillus, Faecalibacterium prausnitzii, butyrate-producing bacteria, mucosa-associated bacteria, fecal bacteria, probiotics, 16S rRNA gene
- MeSH terms
- Adolescent, Adult, Bifidobacterium, Biopsy, Butyrates, Feces, Female, Humans, Intestinal Mucosa, Lactobacillus, Male, Middle Aged, RNA, Bacterial, RNA, Ribosomal, 16S, Inflammatory Bowel Diseases, Gastrointestinal Tract, Young Adult, Biota, Bacterial Load, Real-Time Polymerase Chain Reaction, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.